8-KEarnings & ResultsOther EventsExhibits & Filings

SYNOPSYS INC 8-K Report, Financial Results (Feb 25, 2026)

Filed February 25, 2026For Securities:SNPS

Summary

Synopsys, Inc. (SNPS) has filed an 8-K on February 25, 2026, to announce its financial results for the first fiscal quarter ended January 31, 2026. While the specific financial figures from the earnings release are not detailed within the 8-K itself, the filing indicates that a press release (Exhibit 99.1) was issued containing these results. Investors should refer to this press release for detailed performance metrics, revenue, and earnings per share for the quarter. In addition to the quarterly results, Synopsys also announced a significant enhancement to its capital return program. The company's Board of Directors has replenished its existing stock repurchase program with authorization to purchase up to an additional $2 billion of Synopsys common stock. This demonstrates a continued commitment to returning value to shareholders, although the actual repurchases are discretionary and can be suspended or terminated at any time.

Key Highlights

  • 1Synopsys announced financial results for its first fiscal quarter ended January 31, 2026.
  • 2The earnings release is furnished as Exhibit 99.1 to the 8-K filing.
  • 3The company's Board of Directors authorized an additional $2 billion for its stock repurchase program.
  • 4The stock repurchase program allows for the purchase of up to $2 billion of Synopsys common stock.
  • 5The stock repurchase program is discretionary and can be suspended or terminated by management or the Board.
  • 6The filing incorporates the press release by reference, making it an important document for detailed financial information.

Frequently Asked Questions

The specific financial results are detailed in the press release issued by Synopsys on February 25, 2026, which is furnished as Exhibit 99.1 to this 8-K filing and incorporated by reference.

The company's Board of Directors has replenished the existing stock repurchase program with an authorization to purchase up to an additional $2 billion of Synopsys common stock. The total authorized amount would depend on the specifics of the original program and this replenishment.

No, the stock repurchase program authorizes, but does not obligate, Synopsys to purchase up to $2 billion of its common stock. The company's CEO, CFO, or Board can suspend or terminate the program at any time at their sole discretion.

The disclaimer states that the information in this Current Report on Form 8-K, including the earnings release, shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934 or subject to the liabilities of that section, nor incorporated by reference into other filings unless expressly stated. This is a standard cautionary note to limit liability related to forward-looking statements and specific disclosures.